Showing 1 - 9 results of 9 for search 'Xuanlong Du', query time: 0.04s
Refine Results
-
1
-
2
RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma by Hao Peng, Xuanlong Du, Yewei Zhang, Yewei Zhang
Published 2022-05-01
Article -
3
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma by Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang
Published 2021-08-01
Article -
4
Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and Chinese population by Haidong Zhang, Hui Dong, Zheng Pan, Xuanlong Du, Shiwei Liu, Wenjing Xu, Yewei Zhang
Published 2022-09-01
Article -
5
-
6
-
7
pH-Responsive Pluronic F127–Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer by Jingjing Zong, Hao Peng, Xin Qing, Zhe Fan, Wenjing Xu, Xuanlong Du, Ruihua Shi, Yewei Zhang
Published 2021-04-01
Article -
8
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma by Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Published 2023-05-01
Article -
9
Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database by Haidong Zhang, Xuanlong Du, Hui Dong, Wenjing Xu, Pengcheng Zhou, Shiwei Liu, Xin Qing, Yu Zhang, Meng Yang, Yewei Zhang
Published 2022-07-01
Article